Navigation Links
Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Date:3/31/2008

to continue as a "going concern."

Commenting further, Andrews said, "Given the current uncertainty surrounding the credit markets and our need for access to working capital to support our continued rapid growth, we were pleased to gain access to the capital necessary to enable us to continue to execute our plan. The new Safeguard credit line, along with our renewed facility with Comerica Bank, puts us on solid financial footing from which we can embark on the launch of our new breast cancer test. Based on our improvement in gross margins in 2007, our current commercial growth and our ongoing expense management, we believe we should be able to reduce our operating losses during 2008, which in turn should reduce the amount of additional funds we will need to draw from our newly negotiated line of credit."

The financial results described above reflect the impact of the adjustment to bad debt expense described above, as well as an aggregate $950,000 adjustment to reduce revenue (and record a corresponding liability) that the Company has made to its consolidated financial statements (allocated over a period of multiple quarters) resulting from the Company's analysis of financial information provided to the Company from its third party billing vendor relating to certain credit balances. As a result of matters identified in connection with the Company's year-end financial statement preparation process, management has identified material weaknesses in the Company's internal control over financial reporting. Additional details relating to these material weaknesses and the above-referenced adjustments will be included in the Company's Form 10-K for the fiscal year ended December 31, 2007 to be filed with the Securities and Exchange Commission.

Clarient will discuss fourth quarter 2007 results and certain future expectations on a conference call and live web cast at 8:00 a.m. EDT today. Call information is available at

SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Clarient to Commercialize Novel Breast Cancer Profile
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 PathoGenetix, Inc. , ... rapid bacterial strain typing, announced today that John ... as Vice President of Engineering. Dr. Luckey will ... RESOLUTION™ Microbial Genotyping System . The fully ... pathogen-specific assay kits, database and software, will be ...
(Date:6/18/2013)... DC (PRWEB) June 18, 2013 On ... Services (CMS) released a final decision memorandum concluding ... to guide subsequent management of anti-tumor strategy, and ... collection. The National Oncological PET Registry (NOPR) was developed ... the first projects under the Coverage with Evidence Development ...
(Date:6/17/2013)... MA (PRWEB) June 17, 2013 ... system in March that helps better monitor potentially harmful ... The microAnalyzer V2.0, which was developed by Draper ... Space Station. , Astronauts breathe air that is processed ... to harmful compounds in the air, even in trace ...
(Date:6/17/2013)... 2013 The Defense Threat Reduction Agency ... at the Waterford in Springfield, Virginia on July 22-25 ... will present technical details on their counter weapons of ... broad range of counter WMD areas including: (1) Science ... Science; (3) Science for Protection; (4) Science to Defeat ...
Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2
... 2007 -, - Tests Delivered Grew 68 Percent Compared to ... - Conference Call Today at ... Health,Inc. (Nasdaq: GHDX ) today reported financial results and business progress,for ... million in the first quarter of 2008,compared to $14.1 million in the ...
... Pfizer Enterprise 2.0 expert, to deliver keynote address ... ... Pa., May 6 Simon Revell, Manager of Enterprise,2.0 Technology ... Web 2.0,social software can be leveraged to stimulate the advancement ...
... Awards with ,Blue Ladies, a, Masterpiece of a ... CHICAGO, May 6 AbelsonTaylor, long known ... top honors in the medical device category at ... awards ceremony was part of,the DTC National Conference ...
Cached Biology Technology:Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 9Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 2Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 3AbelsonTaylor Captures DTC Gold 2AbelsonTaylor Captures DTC Gold 3
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
(Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
... Charlie Kerfoot,s doughnut, and all fingers point to a European ... No one knew about the doughnut in southern Lake Michigan, ... Charles Kerfoot and his research team first saw it in ... their research vessels on any of the shipwreck-studded Great Lakes ...
... 17, 2010Colon cancer is the second most common cancer in ... year. It has been known for some time that mutations ... of all sporadic colon cancers. Now researchers at Huntsman Cancer ... featured today in Cell the mechanism by which mutation of ...
... We run our modern lives largely by the clock, from ... herald each new workday to the watches and clocks that ... the like. In addition to those ubiquitous timekeepers, ... biological machinery and which help set our circadian rhythms, regulating ...
Cached Biology News:Death of the 'doughnut' 2Death of the 'doughnut' 3Mechanism behind demethylation pinpointed in APC gene mutants 2Tick tock: Rods help set internal clocks, biologist says 2
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: